The major side effects of delivering anti-cancer drugs, systemically, has warranted a more refined targeted approach. Now researchers say they have the answer by successfully targeting cancer cells with nanorobotic agents. The results may hold promise for refined chemotherapy in patients suffering from various cancers.
The research was a colloboration between the three French-Canadian institutes Polytechnique Montreal, Universite de Montreal and McGill University. The findings were published in the journal Nature Nanotechnology….
Source: Fiercebiotech